Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Diplomacy By Other Means: GPhA CEO Calls Out Amgen Guest

Feb 22 2013

• By Derrick Gingery

Related Content

Biosimilar Meeting Requests Increase, But FDA Cancels Some For Lack Of Data

Dec 12 2012

Sandoz Pushing FDA To Make Biosimilar Interchangeability Decisions

Dec 17 2012

Generic Drug Shortages Threaten Industry’s Reputation, Hamburg Cautions

Feb 27 2012

Biosimilar User Fee Meeting Schedule Allows FDA Data “Pre-Review”

Sep 17 2012

Draft Guidances For 2013 Will Grapple With Biosimilars, Track and Trace, Compounding

Feb 11 2013

GPhA’s Goals For 2013: Smooth GDUFA Implementation, Workable Biosimilar Pathway

Feb 19 2013

Related Companies

Amgen, Inc.

Genentech, Inc.

Additional Topics

United States Legislation Safety BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window